700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Short Communication Open Access
Although effective treatment and good adherence to their DMARDs, some patients with rheumatoid arthritis experience transient worsening in severity of disease for which the causes remain unknown. Here the authors comment the potential contribution of Epstein-Barr virus infection in rheumatoid arthritis and the relationship between such infection and the Toll-like receptor system in the exacerbation of the inflammatory response.
Rheumatoid arthritis, Epstein-barr virus, Anti-rheumatic drugs, Arthritis, Ankylosing Spondylitis, Synovial Fluid, Joint Replacement